Bayer Czech Republic's net debt stood at CZK 393 mil and accounted for 94.4% of equity at the end of 2017. The ratio is down 33.5 pp compared to the previous year.
Historically, the firm’s net debt to equity reached a high of 128% in 2016 and a low of -37.2% in 2008 between 2003 and 2017. The average for the last five years was 59.7%.
Net debt to EBITDA was calculated at 2.49x at the end of the year. That is up from -0.098x seen in 2012. The ratio reached a high of 9.61x in 2007 and a low of -1.03x in 2010.
The company’s cost of funding amounted to 0.929% in 2017, down which is above the 5-year of 4.23%. Funding costs have “eaten” some 2.67% of the operating profit generated in 2019.
You can see all the company’s data at Bayer Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
